Full history for every metric is available with a Kvantra account
Remedium Lifecare Ltd. (REMLIFE.BO)
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | INR bn | 0 | 1 | 5 | 5 | 40 | 4 | 5 |
| Operating profit | INR bn | -0 | 0 | |||||
| Net profit | INR bn | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS reported | INR | 0.06 | 0.12 | |||||
| Operating cashflow per share | INR | -29.94 | 0.00 | |||||
| Capex per share | INR | 29.82 | 0.00 | |||||
| FCF per share | INR | -29.94 | 0.00 | |||||
| Free cash flow | INR bn | -11 | 0 | |||||
| Net debt | INR bn | 11 | 11 | |||||
| Book value equity | INR bn | 0 | 1 | |||||
| Book value per share | INR | 1.15 | 1.22 | |||||
| Number of shares | m | 382.25 | 862.34 | |||||
| DPS (TTM paid) | INR | 0.00 | 0.00 |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 22.80 | 7.64 | |||||
| P/B LTM | x | 1.16 | 0.71 | |||||
| P/S LTM | x | 0.13 | 0.14 | |||||
| P/FCF LTM | x | -0.04 | 0.00 | |||||
| EV/EBITDA LTM | x | 122.73 | 79.26 | |||||
| EV/Sales LTM | x | 2.94 | 2.20 | |||||
| Earnings Yield LTM | % | 4.39% | 13.09% | |||||
| FCF Yield | % | -2251.0% | 0.00% | |||||
| Quality | ||||||||
| ROE | % | 4.85% | 17.45% | |||||
| ROIC | % | -0.05% | 0.56% | |||||
| Operating margin | % | -0.28% | 1.80% | |||||
| Gross margin | % | 1.76% | 3.62% | |||||
| FCF/Sales | % | -282.39% | 0.00% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -93.12% | - | |||||
| Sales Growth YoY | % | -89.97% | -84.25% | |||||
| Net Income Growth YoY | % | -93.49% | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | -86.57% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.00 | 0.00 | |||||
| Net Debt/EBITDA | x | 117.50 | 85.63 | |||||
| EBIT/Net interest | x | -0.21 | 4.93 | |||||
| Net debt/market cap | % | 2242.3% | 1448.9% | |||||
| Net debt/Equity | x | 25.97 | 10.33 | |||||
| Gross debt/equity | x | 26.01 | 10.34 | |||||
Company overview
Remedium Lifecare Ltd. specializes in the distribution of essential raw materials crucial for Active Pharmaceutical Ingredient (API) manufacturing. This encompasses a range of inputs, including key starting materials (KSMs), critical raw materials (CRMs), and other foundational chemical components. Its product portfolio features substances such as Amino isophthalic Acid, Tellurium IV Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI). Established on February 19, 1988, the firm operates from its headquarters in Mumbai, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Remedium Lifecare Ltd. (REMLIFE.BO)
Remedium Lifecare Ltd. specializes in the distribution of essential raw materials crucial for Active Pharmaceutical Ingredient (API) manufacturing. This encompasses a range of inputs, including key starting materials (KSMs), critical raw materials (CRMs), and other foundational chemical components. Its product portfolio features substances such as Amino isophthalic Acid, Tellurium IV Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI). Established on February 19, 1988, the firm operates from its headquarters in Mumbai, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free